Published in Circ Res on July 01, 1983
Coronary microvascular resistance: methods for its quantification in humans. Basic Res Cardiol (2009) 1.26
Modeling [15O]oxygen tracer data for estimating oxygen consumption. Am J Physiol (1996) 1.04
Alpha-adrenergic inhibition increases collateral circuit conductance in rats following acute occlusion of the femoral artery. J Physiol (2008) 1.02
Vascular control in humans: focus on the coronary microcirculation. Basic Res Cardiol (2009) 1.01
Regulation of the human coronary microcirculation. J Mol Cell Cardiol (2011) 0.85
Pharmacology of acute effort angina. Cardiovasc Drugs Ther (1989) 0.84
Coronary microcirculation: autoregulation and metabolic control. Basic Res Cardiol (1995) 0.84
Resistive vessel function in coronary artery disease. Heart (1996) 0.81
Therapeutic targets in ischaemic heart disease. Drugs (1992) 0.80
Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade. Heart (1997) 0.80
Calcium antagonists in myocardial ischemia/reperfusion--update 2012. Wien Med Wochenschr (2012) 0.79
Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris. Cardiovasc Drugs Ther (1989) 0.78
The renin-angiotensin system and coronary vasomotion. Heart (1996) 0.76
Impairment of the myocardial vasomotor response to cold pressor stress in collateral dependent myocardium. Heart (1997) 0.76
Ischemia-selectivity: a new concept of cardioprotection by calcium antagonists. Basic Res Cardiol (1994) 0.75
Significance of cardiac innervation on spontaneous ventricular arrhythmias elicited by left stellate ganglion stimulation in dogs 4 days after myocardial infarction: comparison of two experimental models. Basic Res Cardiol (1993) 0.75
Echocardiographic assessment of coronary artery flow in normal canines and model dogs with myocardial infarction. J Vet Sci (2013) 0.75
Alpha-adrenergic control of coronary circulation in man. Basic Res Cardiol (1995) 0.75
Management of angina pectoris. Modern concepts. Drugs (1992) 0.75
Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res (2000) 3.19
Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci U S A (2001) 2.96
Turnover of adenosine in plasma of human and dog blood. Am J Physiol (1989) 2.26
Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation (1999) 2.20
Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation. Acta Anaesthesiol Scand (2014) 2.02
Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol (1998) 1.69
Low-frequency spectral power of heart rate variability is not a specific marker of cardiac sympathetic modulation. Anesthesiology (1995) 1.65
Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation. Circ Res (1992) 1.54
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand (2011) 1.53
Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol (2001) 1.49
Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res (2001) 1.43
Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation (1993) 1.41
Positron emission tomography analysis of [1-(11)C] acetate kinetics in short-term hibernating myocardium. Circulation (1998) 1.40
Understanding the controversy over the identity of EDRF. Nature (1994) 1.40
Contribution of coronary endothelial cells to cardiac adenosine production. Pflugers Arch (1986) 1.38
Transcutaneous pCO2-monitoring for the evaluation of the anaerobic threshold. Comparison to lactate and ventilatory thresholds. Int J Sports Med (1993) 1.38
Unique cardioprotective action of the new calcium antagonist mibefradil. Circulation (1999) 1.38
Signal transduction of ischemic preconditioning. Cardiovasc Res (2001) 1.38
[The pathophysiology of myocardial circulation. I. Adaptation to myocardial ischemia (the "hibernating" myocardium)]. Dtsch Med Wochenschr (1994) 1.37
Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation (1991) 1.16
G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res (1999) 1.15
Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation (1999) 1.14
Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J Mol Cell Cardiol (2004) 1.13
Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol (1994) 1.12
Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation (1998) 1.12
A vascular transport operator. Am J Physiol (1993) 1.11
Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol (2000) 1.10
Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol (2000) 1.10
Coronary microembolization. J Am Coll Cardiol (2000) 1.07
Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res (1987) 1.04
Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Circulation (1987) 1.03
Ischaemic preconditioning: present position and future directions. Cardiovasc Res (1998) 1.02
The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. J Cardiovasc Pharmacol (1992) 1.00
Intraischemic preconditioning. Increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia without intermittent reperfusion. Circ Res (1995) 1.00
Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol (1990) 1.00
Improved assessment of coronary stenosis severity using the relative flow velocity reserve. Circulation (1998) 1.00
Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation (2001) 0.99
Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am J Physiol (1999) 0.99
Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.99
Myocardial lactate release during ischemia in swine. Relation to regional blood flow. Circulation (1990) 0.98
Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? Circulation (2001) 0.96
Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation (1994) 0.95
Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol (2000) 0.95
Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch (1995) 0.95
The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg (2012) 0.95
Impact of alpha-adrenergic coronary vasoconstriction on the transmural myocardial blood flow distribution during humoral and neuronal adrenergic activation. Circ Res (1993) 0.94
eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol (2001) 0.94
Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? Br J Pharmacol (2014) 0.93
Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism. Br J Pharmacol (2000) 0.93
Connexin 43 signalling and cardioprotection. Heart (2005) 0.93
Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circulation (1987) 0.93
No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. J Mol Cell Cardiol (2000) 0.91
The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits. Br J Pharmacol (2010) 0.90
Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol (1984) 0.90
Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension (1995) 0.89
Left ventricular asynchrony: an indicator of regional myocardial dysfunction. Am Heart J (1990) 0.89
Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion. J Mol Cell Cardiol (2000) 0.89
Consequences of regional inotropic stimulation of ischemic myocardium on regional myocardial blood flow and function in anesthetized swine. Circ Res (1989) 0.88
Measurement of the endogenous adenosine concentration in humans in vivo: methodological considerations. Curr Drug Metab (2008) 0.87
No effect of coronary perfusion on regional myocardial function within the autoregulatory range in pigs. Evidence against the Gregg phenomenon. Circulation (1991) 0.87
Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol (1998) 0.87
Ischemic myocardial dysfunction assessed by temporal Fourier transform of regional myocardial wall thickening. Am Heart J (1987) 0.87
Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res (1988) 0.86
Genetic interactions in the β-adrenoceptor/G-protein signal transduction pathway and survival after coronary artery bypass grafting: a pilot study. Br J Anaesth (2011) 0.86
Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses. J Cardiovasc Pharmacol (1984) 0.86
Acetylcholine induces constriction of epicardial coronary arteries in anesthetized dogs after removal of endothelium. Arzneimittelforschung (1985) 0.86
Static filling pressure in patients during induced ventricular fibrillation. Am J Physiol Heart Circ Physiol (2003) 0.86
Post-ejection wall thickening as a marker of successful short term hibernation. Cardiovasc Res (1993) 0.86
Inorganic phosphate content and free energy change of ATP hydrolysis in regional short-term hibernating myocardium. Cardiovasc Res (1998) 0.86
Regional myocardial blood flow, function and metabolism using phosphorus-31 nuclear magnetic resonance spectroscopy during ischemia and reperfusion in dogs. J Am Coll Cardiol (1987) 0.85
X-ray densitometry for the measurement of regional myocardial perfusion. Basic Res Cardiol (2000) 0.85
Heart rate variability and circulating catecholamine concentrations during steady state exercise in healthy volunteers. Br Heart J (1993) 0.85
Insulin effects on myocardial function and bioenergetics in L-bupivacaine toxicity in the isolated rat heart. Eur J Anaesthesiol (2007) 0.85
Glutamate degradation in the ischemic dog heart: contribution to anaerobic energy production. J Mol Cell Cardiol (1989) 0.85
Clonidine prevents the sympathetic initiation and aggravation of poststenotic myocardial ischemia. J Cardiovasc Pharmacol (1986) 0.84
Regional short-term myocardial hibernation in swine does not involve endogenous adenosine or KATP channels. Am J Physiol (1995) 0.84
No involvement of nitric oxide in the limitation of beta-adrenergic inotropic responsiveness during ischemia. Am J Physiol Heart Circ Physiol (2001) 0.84
AT1 receptor blockade in experimental myocardial ischemia/reperfusion. Basic Res Cardiol (1998) 0.84
Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. J Cardiovasc Pharmacol (1995) 0.84
Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitors. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.84
Release of endothelium derived nitric oxide in relation to pressure and flow. Cardiovasc Res (1991) 0.84
Minimal protection of the liver by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol (2001) 0.84
Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs. Am J Physiol Heart Circ Physiol (2001) 0.84
AT1 receptor blockade in experimental myocardial ischemia/reperfusion. J Am Soc Nephrol (1999) 0.83
Genetic determinants of coronary vasomotor tone in humans. Am J Physiol Heart Circ Physiol (2001) 0.83
Favorable remodeling enhances recovery of regional myocardial function in the weeks after infarction in ischemically preconditioned hearts. Circulation (2000) 0.82
Characteristics of regional myocardial stunning after exercise in dogs with chronic coronary stenosis. Am J Physiol (1989) 0.82
Effects of left circumflex Ameroid constrictor placement on adrenergic innervation of myocardium. Am J Physiol (1987) 0.82
Acute alcohol-induced protection against infarction in rabbit hearts: differences from and similarities to ischemic preconditioning. J Mol Cell Cardiol (2001) 0.82
Spatial heterogeneity of energy turnover in the heart. Pflugers Arch (2001) 0.82
Postextrasystolic potentiation does not distinguish ischaemic from stunned myocardium. Pflugers Arch (1991) 0.82
Coronary microembolization--its role in acute coronary syndromes and interventions. Herz (1999) 0.82
Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia. Eur Heart J (1987) 0.82
No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res (1996) 0.82
Ischemic preconditioning through opening of swelling-activated chloride channels? Circ Res (2001) 0.82
Diastolic dysfunction and collagen structure in canine pacing-induced heart failure. J Mol Cell Cardiol (1999) 0.81
Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemia. J Auton Nerv Syst (1985) 0.81